All posts by imreal

Medgaus Dental Group Relieves Dental Anxiety in Monroeville, PA through Fast, Calming Sedation Dentistry


Dr. Carl Medgaus, Dentist in Monroeville and Pittsburgh, PA

Dr. Carl Medgaus Reduces Dental Anxiety in Monroeville, PA

We have some local anesthetics now that are so powerful and so profound in a small dosage that you could have anything done in your mouth and you would never feel a thing.

Trusted dentists, Dr. Carl Medgaus and Dr. Maelys Aguila of Medgaus Dental Group, raise awareness of sedation dentistry treatment solutions in Monroeville, PA. This team understands that dental anxiety and fear can prevent patients from receiving the care their oral and overall health needs. To ease their fear of going to the dentist, Medgaus Dental Group offers customized sedation solutions for any visit, from the simplest cleaning to the most complex full mouth dental implants surgical treatment.

Dental anxiety, also referred to as dental fear, remains a stumbling block for many young and adult patients who require necessary care for their teeth and gums. When properly applied to address an individual’s unique situation and preferences, sedation dentistry can become a reliable tool to promote comfort and calm during any procedure. Normally, sedation dentistry can also shorten the overall time spent in the dentist’s chair, maximizing treatment results.

Medgaus Dental Group offers in-house local sedation, oral sedation, nitrous oxide and even IV sedation. Local sedation involves injections that numb a particular location in the mouth by blocking pain receptors. Oral sedation allows patients to take medication orally before coming into the office. This solution produces a sense of relaxation throughout their visit. A sedation dentistry favorite, nitrous oxide offers complete and immediate relaxation shortly after inhaling the sedative.

Finally, IV sedation features medicines introduced through the veins under close monitoring. The team at Medgaus Dental Group partners with an experienced anesthesiologist to offer IV sedation in-office for their patients’ convenience. Those who present with severe dental anxiety or who require more advanced surgical treatment routinely prefer IV sedation. With privileges to work in the operating room at the Aestique® Surgical Center in Greensburg, PA, Dr. Medgaus is also equipped to handle critical surgical cases with general anesthesia. Accredited by the American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF), Aestique® offers the highest level of safety.

“We have some local anesthetics now that are so powerful and so profound in a small dosage that you could have anything done in your mouth and you would never feel a thing,” says Dr. Medgaus, explaining the effects sedation dentistry has on his patients. “So, it’s always amazing! Patients will say, ‘I just have no pain anymore!’ When the anesthetic wears off, the treatment can be so effective that there’s no pain afterward as well.”

Those who want to talk with Dr. Medgaus or Dr. Aguila about sedation dentistry or their revolutionary full arch dental makeover protocol, Stabili-Teeth™ are invited to call either of Medgaus Dental Group’s locations to arrange a one-on-one consultation. The Pittsburgh office can be reached by calling 412-563-6333, and the Monroeville office by dialing 412-373-0310.

About the Dentists

For over 35 years, Medgaus Dental Group has been serving the Monroeville and Pittsburgh, PA areas with genuine and comprehensive dental care. Founder and lead dentist, Dr. Carl Medgaus, is dedicated to continuing education for himself as well as his fellow clinicians. Having treated over 300,000 patients since 1973 and placing over 2,500 dental implants, his results speak for themselves. His associate, Dr. Maelys Aguila, is a native Spanish speaker who shares the same philosophy that changing a smile can change a life. Developing his own full arch dental implant technique, Stabili-Teeth™ Dr. Medgaus and his team also offer life-changing smile makeovers and gum disease treatment, among other services. To learn more about Drs. Medgaus and Aguila, their leading-edge practice, or the services they offer, visit http://www.medgausdentalgroup.com or call their Monroeville office at 412-373-0310 or their Pittsburgh practice at 412-563-6333.

Share article on social media or email:

Austin Dental Implant Center Reopens with New Safety Guidelines, Offers Comprehensive Dental Implant Treatment


Drs. Dan Holtzclaw and Juan Gonzalez, dental implant specialists in Austin, TX

Drs. Dan Holtzclaw and Juan Gonzalez, Dental Implant Specialists in Austin, TX

With previously limited access during the novel coronavirus pandemic, these dental implant specialists are eager to reopen and provide the care their patients need to maintain a functional and healthy life.

Renowned practice,Austin Dental Implant Center, welcomes new and existing patients for complete and comprehensive dental implant care in Austin, TX. With previously limited access during the novel coronavirus pandemic, these dental implant specialists are eager to reopen and provide the care their patients need to maintain a functional and healthy life. Implementing new sanitary and safety guidelines and using personal protection equipment (PPE), Austin Dental Implant Center remains the leading and trusted source for specialized dental implant treatment in the Austin area and across the country.

Austin Dental Implant Center takes a unique approach to implantology. Combining multiple specialists into one office along with the leading-edge technology they require for truly life-changing care and lasting results, they offer a tooth replacement experience hard to find elsewhere.

Using their in-house CAT-scan imaging technology, they can see an in-depth view of each patient’s treatment site, improving diagnostics and surgical planning. Although only local sedation is required in most cases, hospital-grade sedation monitors are located in each room. Instead of visiting multiple offices and sending restorations to third-party labs, they offer comprehensive treatment in-house using their own dental lab. Patients can not only receive their dental implant surgery from Austin Dental Implant Center, but their final, natural-looking crowns or bridges from one team, and one location. With technology from industry-leaders like Zirkonzahn™ milling, and Carbon™ 3D printing, they digitally plan each prosthetic for an accurately and precisely crafted smile that is unique to each patient.

Beyond saving time and minimizing visits through their advanced technology and comprehensive approach to tooth replacement, the team at Austin Dental Implant Center offers high-quality care through practiced techniques. They exclusively offer the DIAsmile™ technique, created by their founder, Dr. Dan Holtzclaw. This same-day full mouth dental implants treatment can improve patients’ bone health and oral health, and has been seen to offer lasting effects on their overall health as well. Through improved self-confidence, diet, and overall oral function, patients who receive DIAsmile™ or even single dental implants from the Austin Dental Implant Center, have seen long-term and life-changing results.

Dr. Holtzclaw and Dr. Juan Gonzalez are leaders in the field of implantology. With decades of combined experience, they have placed over 25,000 dental implants throughout their careers. With over 60 publications in renowned dental journals on topics including dental implants and immediate full mouth dental implant solutions, they have also given over 200 lectures at podiums across the country as well as internationally.

For the wellbeing of their patients and their staff, this team is implementing new safety measures in addition to their already thorough existing sanitary guidelines. Before and after each patient visit, they sanitize the patient room including any surfaces or equipment used. In addition, they have increased the frequency of their regular deep cleanings for each room and the entire office. They will closely monitor any changes in guidelines or recommendations made by the Centers for Disease Control and Prevention (CDC) and the American Dental Association (ADA) as well as local and federal authorities.

To learn more about Austin Dental Implant Center, their new safety measures during COVID-19, or their unique approach to dental implant treatment in Austin, TX call 512-375-0050.

About the Practice

Austin Dental Implant Center was founded by Dr. Dan Holtzclaw, one of the world’s leading authorities on full arch immediately loaded dental implant treatment. Using experience from thousands of dental implant procedures, Dr. Holtzclaw pioneered the DIAsmile™ implant teeth-in-a-day treatment concept, which allows patients to receive a new dental implant smile in just one day. With an in-house laboratory utilizing world-class Zirkonzahn™ technology, staff oral surgeons, staff prosthodontists, and experienced dental technicians, Austin Dental Implant Center is able to provide industry leading dental implant treatment in one convenient location, eliminating the need for patients to travel to multiple offices, as is required with most traditional dental offices. To learn more about the DIA Dental Implant Center advantage visit http://www.austindentalimplantcenter.com or call 512-375-0050.

Share article on social media or email:

altumAI EXTENDS futureWork PLATFORM TO SUPPORT BUSINESSES RETURNING TO WORK


futureWork Return to Work Solution

“futureWork is uniquely positioned to deliver and help businesses return to work.”

altumAI announced today that futureWork, the leading worker health and safety software and apps platform have extended the solution to support businesses returning to work.

futureWork was launched in 2017 with a core focus of using technology and data to protect worker health and safety. Since inception, futureWork businesses have monitored their workers risk using the futureWork Supervisor and Worker applications to mitigate risk on the jobsite. The mobile enabled software and apps give organizations insight to understand and avoid risk across organizations with aggregated risk scores, micro-training, coaching, and messaging. futureWork provides workers with tailored insight to understand and avoid their individual risk with risk scores, micro-training, and messaging.

futureWork’s latest Screener and Guest apps and software supports the Centers for Disease Control and Preventions new recommended employer return to work guidelines around education, self-screening, and administrative controls. “While CV-19 has disrupted every aspect of business across the US, one common thread across all industries is that worker health and safety has never been more important,” said Douglas Turk, CEO of altumAI. “futureWork supports the State return to work guidelines of Employee Education, Self-Screening, and Individual Control Measures. Each of these is centered on providing the right information and data to the worker and ensuring communication and engagement occurs across an organization. futureWork is uniquely positioned to deliver and help businesses return to work.”

Learn more about altumAI futureWork Return to Work Program here.

About altumAI

altumAI, the company behind futureWork, uses data, technology, and AI to protect worker health and safety. futureWork is the leading worker health and safety application platform for real-time, mobile-enabled risk awareness, communication, and engagement. futureWork captures and interprets the data that surrounds every worker to identify and avoid risk. To learn more about how altumAI can help your business, please visit http://www.altumai.com.

Share article on social media or email:

GoGreen Hemp Announces Product Extension With New CBD Stick


GoGreenHemp CBD Relief Stick

“I personally wish I had the chance to use our CBD stick when playing college basketball, my joints and muscles would have benefited exponentially.” – Romas Marcinkevicius, Founder

GoGreen Hemp, a leading CBD wellness company providing quality, third party laboratory tested, and certified CBD products, is proud to announce the release of the GoGreen Hemp CBD Stick. GoGreen Hemp remains committed to its purpose of providing consumers with clean and effective CBD products. This CBD topical product is a real game-changer and provides consumers with a convenient and effective way of using CBD in topical form.

CBD topical products have remained one of the strongest categories in the CBD space year over year, and is one of GoGreen Hemp’s top selling categories. These topicals are extremely effective in targeting external pain and inflammation, giving consumers the ability to apply CBD directly to the area(s) of discomfort. It also gives consumers the chance of trying CBD without digesting it orally, giving new users more confidence when trying CBD for the first time.

“Just over 20% of the American adult population deals with chronic pain, we have made it a priority this year to expand our CBD topical line, giving consumers more options to choose from” said GoGreen Hemp Founder Romas Marcinkevicius. “ I personally wish I had the chance to use our CBD stick when playing college basketball, my joints and muscles would have benefited exponentially.”

Less is more, carefully crafted with your wellness in mind, the CBD stick contains only three natural effective ingredients; Beeswax, MCT oil, and broad spectrum CBD. These three natural ingredients are packed in a stick that offers consumers a convenient way of getting effective targeted relief.

The 2.2 oz. CBD Stick is loaded with 1000mg of broad spectrum CBD with a suggested retail price (SRP) of 64.99. Like all GoGreen Hemp products, it is THC-Free, non-GMO, and has full traceability from seed to sale to ensure both safety and effectiveness.

The CBD stick is the newest addition to GoGreen Hemp’s diverse product line following the recent addition of their 1oz. 2000mg strength balm salve. Today GoGreen Hemp is proudly offering 17 different highly effective topical product variations.

GoGreen Hemp is now focused on developing their product line further and registering numerous CBD topical products with various state health departments, staying one step ahead of the curve in anticipation of the FDA regulation later this year. For more information on GoGreen Hemp please visit http://www.gogreenhemp.com

About GoGreen Hemp:

GoGreen Hemp offers customers quality CBD products, exclusively derived from organically grown American hemp and manufactured to the highest standards. Our products are tested numerous times throughout the production process both internally and through third party laboratories, which are readily available on our website. We take pride in transparency and understand that trust comes from transparency. All of GoGreen Hemp products have full traceability from seed to sale to ensure customers receive safe and effective products each and every time. GoGreen Hemp is located in Plantation, Florida and is one of the oldest CBD-only companies in the relatively young industry. GoGreen Hemp’s ambition is to provide CBD globally, increase overall consumer knowledge in the CBD space, and ultimately become a leader in the CBD industry. Visit GoGreen Hemp at gogreenhemp.com and on Instagram @gogreenhemp

Share article on social media or email:

Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control


SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to report a new study that has shown that targeted treatment to areas of cancer inside a prostate previously treated for cancer using radiotherapy is effective and has low risk of side effects. The study was carried out in men in whom prostate cancer had recurred following radiotherapy. The study is to be presented at the international ASCO (American Society of Clinical Oncology) cancer meeting on 29th May 2020.

Every year, about 30,000 to 50,000 men with prostate cancer in the U.S. are treated with radiotherapy. This is an effective treatment for prostate cancer but about 30% of men will have evidence of recurrent disease within five years. Patients who have a cancer recurrence contained within the prostate are traditionally offered anti-testosterone hormone treatment. While effective at limiting the disease, it does not eliminate the disease and must be taken for life in lieu of another intervention. Courses of hormone treatment can cause side effects such as obesity, tiredness, and bone thinning, and can also increase the risk for diabetes and heart disease. An alternative is radical salvage surgery (called salvage prostatectomy) which removes what is left of the prostate after radiation. This procedure is difficult to perform after radiation therapy because the tissues surrounding the prostate are scarred and stuck down secondary to the radiation. Among men who receive a salvage prostatectomy, 50-100% get urine leakage needing daily pads and 5-10% get rectal injury that may require a colostomy or other major reconstructive surgery.

Focal therapy uses different forms of energy, noninvasively or minimally invasively, to target and treat selectively only those regions of the prostate where cancer has recurred. The form of energy used by Sonablate is high intensity focused ultrasound (HIFU). Unlike prostatectomy surgery, HIFU is delivered without incisions. Most men go home the same day pain free and are back to work within several days; this is weeks to months sooner than what is seen with a salvage prostatectomy.

At 356 patients, this current study is the largest ever and with the longest follow-up to come out of the UK. At six years, 3 out of 4 patients treated with focal therapy had their cancer controlled and did not need hormones or surgery. Cancer specific survival was 97.2%. The procedure is also safe; less than 1 in 100 patients had a significant complication. Rectal injury was 0.3% while the researchers have shown in another study that urine leakage needing pads after salvage HIFU was only 12.5%.

Professor Hashim Ahmed, senior researcher for this study, which was performed at Imperial College NHS Foundation Trust and Imperial College London, said that, “Radiotherapy is effective in most men but for the thousands of men with recurrent prostate cancer after radiotherapy, the options are very limited. Focal therapy for these patients offers a treatment for their cancer that does not carry the high risk of side-effects from traditional hormones or major surgery.”

Dr. Deepika Reddy, a urology research doctor, and lead author on the study, based at Imperial College NHS Foundation Trust and Imperial College London, said, “This study provides more evidence that focal therapy should be considered in men whose cancer is suitable for a minimally-invasive approach. Such evidence in combination with well-structured clinical trials will help patients, in partnership with their doctors, work out the most suitable option for them.”

Dr. Mark Carol, SonaCare Medical CEO and President, said, “One of the first clinical uses for Sonablate HIFU in the U.S. was for the treatment of recurrent prostate cancer status post radiation therapy. The U.K. has taken the lead in developing and demonstrating the value of HIFU for many stages of prostate cancer. This paper continues the amazing track record Professor Ahmed and his team have established in proving and promoting the value of HIFU.”

Link to Abstract

Since Sonablate® received FDA clearance on October 9, 2015, thousands of patients have had a Sonablate HIFU prostate procedure across the 60+ locations in the U.S., including top-tier academic institutions in California, Indiana, Oklahoma, Maryland, New York, Arizona and Texas. Over 70 U.S. physicians now offer HIFU prostate tissue ablation to their patients as a minimally invasive alternative to surgery or radiation. Sonablate is also used in more than 30 countries worldwide, and is the de facto standard for delivering HIFU to men in the U.K.

Sonablate® has 501(K) clearance in the U.S. and is indicated for the transrectal high intensity focused ultrasound (HIFU) ablation of prostate tissue. Caution: Federal (USA) law restricts this device to sale by or on the other of a physician

ABOUT SONACARE MEDICAL, LLC

SonaCare Medical is a world leader in minimally invasive focused ultrasound technologies. SonaCare Medical is committed to developing focused ultrasound related technologies that support precise and innovative procedures for the treatment of a range of medical conditions. SonaCare Medical, with its subsidiary Focus Surgery, Inc., designs and manufactures medical devices, including the following: Sonablate®, which has 501(K) clearance in the U.S.; Sonablate®500, which has CE Marking and has obtained regulatory authorization in more than 50 countries outside the U.S., Sonatherm® laparoscopic HIFU surgical ablation system, which has 510(K) clearance in the U.S., has CE Marking and has obtained regulatory authorization in more than 30 countries outside the U.S.

For additional information, visit http://www.SonaCareMedical.com

COMPANY CONTACT:

SonaCare Medical, LLC

Karen Cornett (704) 805-1885 KarenCornett@SonaCareMedical.com

ABOUT IMPERIAL COLLEGE LONDON

Imperial College London is a world top ten university with an international reputation for excellence in teaching and research. Consistently rated amongst the world’s best universities, Imperial is committed to developing the next generation of researchers, scientists and academics through collaboration across disciplines. Located in the heart of London, Imperial College is a multidisciplinary space for education, research, translation and commercialisation, harnessing science and innovation to tackle global challenges.

ABOUT IMPERIAL PROSTATE

Imperial Prostate is a world-leading team of researcher-practitioners who work towards improving the lives of men who develop or are being investigated for prostate cancer and other prostate diseases. The group’s mission is to improve the speed, accuracy and safety of prostate disease diagnosis, and to evaluate new treatments which have fewer side effects than standard techniques without losing treatment efficacy. It is partnered with scientists at Imperial College, who help us develop our research based on the latest scientific discoveries, techniques and technology.

Imperial College Healthcare NHS Trust is one of the largest hospital Trust’s in England, providing acute and specialist healthcare for a population of nearly two million people. The Trust has five hospitals – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – as well as community services.

ABOUT PROST8 UK CHARITY

Prost8 UK charity: 1182590 is a UK charity concentrating on the major advances in minimally invasive prostate cancer treatment enabled through focal therapy. Among the important benefits this treatment pathway provides is low cost treatment at point of delivery with fast recovery times and low lifestyle impacting outcomes over a long period. Focal therapy includes HIFU (high intensity focal therapy), which uses ultrasound to generate points of heat, and cryotherapy, which uses extreme cold, to target and destroy cancer tumours with minimal damage to surrounding tissue and organs. Prost8 UK are campaigning to create awareness of the availability of focal therapy for prostate cancer as up to 12,000 men each year in the UK could benefit from this treatment, if they know to ask. More than 95% of men with a diagnosis will currently not be informed of this less invasive treatment option which will be the primary focus of Prost8’s ‘Prostate Cancer – Know Your Choices’ campaign launching in June 2020. The charity is currently also actively fundraising £5m to buy, donate and deploy focal therapy equipment into the NHS across the UK to rapidly increase access to this treatment. Following the important outcomes of this trial Prost8 UK will also be actively supporting Imperial Prostate to promote awareness among the general public, GP’s and urological practitioners of the potential for prostate lumpectomy treatment via focal therapy for men with recurrent cancer following earlier radiotherapy treatment.

Contact Details:

Paul Sayer (CEO) 07946 511176 paul.sayer@prost8.org.uk

prost8.org.uk

IMPORTANT

Men who are concerned about prostate cancer should in the first instance discuss this with their family doctor (GP). Queries from patients, GPs and consultants can also be forwarded to imperial.prostate@nhs.net but GP or consultant referrals will be needed for those men who wish to discuss their eligibility for the treatment. The following websites have further information: http://www.imperialprostate.org.uk and https://www.prost8.org.uk

FOR FURTHER INFORMATION

Contact Details:

Imperial.prostate@nhs.net

Deepika.reddy06@imperial.ac.uk

SONACARE MEDICAL FORWARD LOOKING STATEMENTS

The Company’s forward-looking statements are based on management’s current expectations and assumptions regarding the Company’s business and performance, the economy and other future conditions and forecasts of future events, circumstances and results. As with any projection or forecast, forward-looking statements are inherently susceptible to uncertainty and changes in circumstances. The Company’s actual results may vary materially from those expressed or implied in its forward-looking statements. Any forward-looking statement made by the Company speaks only as of the date on which it is made. The Company is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements, whether as a result of new information, subsequent events or other factors.

Biocompare Releases Documentary on “Technologies That Enable Immunotherapies”


Documentary: Technologies That Enable Immunotherapies

Documentary: Technologies That Enable Immunotherapies

Immunotherapies have absolutely changed the way researchers and clinicians are approaching cancer treatment

Biocompare, the leading online information resource for the life sciences, has released a documentary entitled “Technologies That Enable Immunotherapies”. This four-part video takes an in-depth look at how the development of more robust analytical tools has impacted Immunotherapies, one of the most exciting areas of cancer therapeutics available today.

“Immunotherapies have absolutely changed the way researchers and clinicians are approaching cancer treatment,” explains Michael Okimoto, Ph.D., Chief Content Officer of CompareNetworks, the parent company of Biocompare, “And the tools that are used to analyze, assess and monitor these therapies are becoming more and more powerful. We felt that it’s important to educate the life science community about exactly what these tools can and cannot do to help them allocate their resources appropriately.”

As treatments like checkpoint inhibitors and CAR T-cell therapies become the standard of care for many different malignancies the types of information needed about the individual cancers become greater. This includes things like whether or not there are infiltrating lymphocytes, what the genomic profile is, what the proteomic profile looks like, how the tumor is changing over time and much more. There are many different technologies to perform these types of analyses and knowing which one is best suited for each question is an important part of ensuring the treatment will be a success.

“It has been clear that Immunotherapies have been a major focus for many biotechnology and pharmaceutical companies for some time,” says Joan Boyce, Vice-President and General Manager of Biocompare, “But we felt there was a need for a piece that puts the different analytical technologies side by side to make it clear what questions each is best suited to answer.”

About Biocompare

Biocompare, a Division of CompareNetworks, Inc., is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative resource that enables them to make better product, technology, and service purchasing decisions. Produced by scientists, Biocompare’s mission is to provide free, time-saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education. For more information, please visit https://www.biocompare.com.

Share article on social media or email:

Business Insurance Industry Veteran Jennifer M. Schirtz Joins Poms & Associates as Vice President of Insurance Placement


Poms & Assoc. Logo

“Jennifer brings a lifetime of business insurance experience and expertise and is a key addition to our diverse leadership team who devise creative and cost-effective approaches to unique problems for our clients.” – David Poms, founder and president of Poms & Associates

Poms & Associates, an independent, full-service insurance brokerage and risk management firm, today announced the hire of Jennifer M. Schirtz as its vice president of insurance placement. In her role, Schirtz is responsible for managing relationships with insurance carriers to ensure the effective placement of all commercial lines for the best available terms, conditions and pricing with Poms & Associates producers and service teams.

“We’re excited about Jennifer joining Poms & Associates,” said David Poms, founder and president of Poms & Associates. “She brings a lifetime of business insurance experience and expertise and is a key addition to our diverse leadership team who devise creative and cost-effective approaches to unique problems for our clients.”

Schirtz joins Poms & Associates from HUB International Insurance Services, Inc., headquartered in Chicago and ranked 5th among the world’s largest insurance brokerages. At HUB International, she worked as an account executive since 2006. Before then, she worked as an independent commercial insurance broker. A graduate of California State University-Northridge, Schirtz is a Certified Risk Manager (CRM), a Certified Insurance Counselor (CIC) and a Certified Insurance Service Representative (CISR).

For more information about Poms & Associates, visit https://pomsassoc.com/.

About Poms & Associates

Poms & Associates is a leading independent, full-service insurance brokerage and risk management firm with a proven track record of providing innovative and customized solutions to businesses in high-risk industries. Founded in 1991, the company was built on the premise that knowledge is the best insurance – that is, the best way to help businesses and organizations is to serve not only as an insurance broker but also as an educator about best practices in how to reduce risk and prevent loss before an incident occurs. Poms & Associates today offers a wide range of products and services, including property and casualty insurance for commercial organizations and public entities, risk control, human resources and employee benefits and private services for high net-worth individuals. Among the top 50 independent brokerage firms in the U.S., Poms & Associates is headquartered in Woodland Hills, Calf. It maintains branch offices in Los Angeles, Sacramento, Calif., the San Francisco Bay Area, Albuquerque, N.M. and Dayton, Ohio. For more information, visit https://pomsassoc.com/.

Share article on social media or email:

Protective Mask Company That Gives Back, Maskwell, Launched by PureFilters and Now Creative Group


News Image

In response to the COVID-19 pandemic, Toronto entrepreneurs have launched Maskwell, a collaboration between air filter e-commerce startup PureFilters and marketing agency Now Creative Group, in response to the growing shortage of protective masks. Maskwell produces reusable locally designed masks for everyday life featuring high-efficiency air filters while supporting frontline healthcare workers with every purchase.

Launched in April 2020, Maskwell entered the market as an accessible, affordable Canadian option for high-quality filter masks. Fitted with the same quality of materials used in MERV-13 filters, each mask comes with a set of replaceable filters, and the ability to subscribe for fresh filter refills.

Created with its core values in mind, Maskwell thrives on being accessible community-driven and informative. The simple yet effective design highlights quality at the forefront of the Maskwell approach. With expertise from the founders of PureFilters, Maskwell promotes the important correlation between clean air and good health.

As COVID-19 has affected communities, organizations and medical facilities across the country, Maskwell’s social impact is at the core of its operation. From day one, Maskwell partnered with The Home Front to provide PPE and medical supplies to charities working on the frontlines. Ten percent of all sales are being donated to The Home Front, with the first donation made within two weeks of launching pre-orders at getmaskwell.com.

The Home Front’s co-founder and Executive Director of The Upside Foundation Jen Couldrey stated that the organization has been very impressed to see the team launch Maskwell so quickly to respond to one of the most urgent needs in the world right now.

“We are deeply humbled by their commitment to giving back to the organizations that need their support the most through the proceeds generated from this social enterprise. Huge kudos to them for stepping up and showing leadership during this time.”

The Maskwell team also participated in a national technology challenge by Canadians for the world called #HackTheCurve, to develop a solution that could alleviate some of the greatest difficulties being faced by Canadians as a consequence of COVID-19.

“It’s been great to see the progress Maskwell has made since participating in the HackTheCurve program,” said Shane Flynn, Ryerson DMZ’s Director of Incubator & Alumni Relations.

“The success they’re seeing commercially, and philanthropically through their donation program is a testament to the hustle and passion the team has. It was an absolute pleasure to be able to mentor them during the virtual program, and I can’t wait to see what they accomplish going forward.”

For businesses currently open and scheduled to re-open, Maskwell provides corporate rates on masks that help protect employees in sectors such as retail, hospitality, delivery and other essential organizations.

As businesses begin to re-open, Maskwell has committed to supporting local small businesses by running a mask giveaway for business owners and their staff. Nominations are being accepted through Instagram @getmaskwell.

Nadir Chaudhry, the co-founder of PureFilters and Maskwell, was inspired to take action in launching the mask company.

“When worries of the pandemic started to materialize, I became aware of the massive problem of personal protective equipment shortages that front line workers were facing. Having quite a few doctors and nurses in my personal life, I was naturally concerned and wanted to do something about it. I realized it was possible to repurpose the high-efficiency filtration media we use at PureFilters and use it to create a filter on masks. After weeks of tireless communication with existing mask makers, I was unable to find the right partner. Ultimately I decided to create the perfect solution alongside the team at Maskwell: re-usable masks that feature high-efficiency replaceable filters.”

About Maskwell:

Maskwell builds re-usable masks that feature high-efficiency replaceable filters to help keep people healthy during uncertain times. Launched in 2020, the company donates a portion of all sales to support those on the frontlines.

About PureFilters:

PureFilters was founded with a mission of making superior indoor air and water quality simple and affordable, as it is essential to wellbeing. Founded in 2013, the company’s dedication to customer service and satisfaction has enabled PureFilters to become a household name in Canada.

About Now Creative Group:

Now Creative Group is fueled by entrepreneurial thinking and positive impact. The agency focuses on strategic branding paired with quality content to share stories, create change, and enable growth. Recipients of a Business Excellence Award and Social Good Design Award, Now was founded in 2013 and is based in Toronto.

Share article on social media or email:

Body’s By Dubs Helps Clients Stay Home, Stay Safe and Stay Fit with Expert Virtual Fitness, Training and Nutrition Programs


The organization has taken its expertise online to help clients stay fit during the COVID-19 pandemic.

Body’s By Dubs has introduced virtual fitness, training and nutrition programs.

“With the pandemic, life has changed considerably but health should not be put on the back burner. Our online program encourages people to stay safe and stay fit. We’ve been really encouraged by the feedback from people who appreciate the flexibility and the privacy the program allows.”

Take one look at Dubs and its hard not to aspire to his level of fitness. He is, quite frankly, what the proverbial picture of health probably looks like. Yet, this muscle-bound personal trainer who believes in a holistic approach to wellness, was once the scrawny kid who was on the outside looking in, so to speak. Not anymore. For nearly 10 years, his business, Body’s By Dubs, has helped individuals change their own body compositions and be their best selves. Now he’s taken his expertise online to help clients stay home, stay safe and stay fit during the COVID-19 pandemic.

Body’s By Dubs offers online personal training and a meals and nutrition program for a national audience; and in “normal” times, in-home training and a popular bootcamp for Dallas area residents. Clients come to Dubs for help with weight loss, strength and muscle-building training, injury rehab, general workouts for improved fitness, and group fitness. Dubs is, in fact, certified by the National Academy of Sports Medicine, is a weight loss specialist, and even CPR-certified by the American Heart Association – with a 12-year record of success in helping clients attain their goals.

“I was a skinny kid who didn’t eat as well as I should have and didn’t have a lot of strength despite being active in sports. In college, I was around a lot of athletic guys who dedicated time to training and paid attention to what they ate. I decided to emulate them and take better care of myself. I’ve never looked back,” explained Dubs. “Now I use that hindsight and my expertise to relate to my clients and build programs individualized to what they envision for themselves – and work side by side with them to make that happen.”

These days, that training looks a little different as it is mainly via its online program, yet what has not changed is the personalized approach. After a one-on-one consultation via Skype, Dubs and his team develop a meal and workout plan just for them. And as the program has caught on, they have discovered that many new clients prefer the privacy and flexibility that comes with it.

“With the pandemic, life has changed considerably but health should not be put on the back burner. Our online program encourages people to stay safe and stay fit,” he said. “We have been really encouraged by the feedback from people who appreciate the flexibility and the privacy the program allows.”

Body’s by Dubs offers a variety of meal and workout plans and virtual personal training services at affordable prices. For more information, go to bodysbydubs.com.

Share article on social media or email:

Presentation to Highlight Key Thought Leaders


News Image

“The new Cone Beam CT Accreditation Program will establish the most detailed standards for specialty imaging that are available for this emerging market,” adds Dr. Harrell.

RadSite™, a CMS-recognized accrediting agency promoting quality-based advanced diagnostic imaging, is offering a complimentary webinar called 2020 RadSite ConeBeam CT Standards Overview. The webinar will take place on June 17th, 2020, at 2:00 p.m. ET and will last approximately one hour. Click here to register.

“Cone Beam CT imaging represents a new and innovative way to image for certain specialty exams, including dental/maxillofacial, ENT, mammography, orthopedics, and podiatry,” notes Garry Carneal, JD, RadSite President and CEO. “The webinar will highlight the opportunities and challenges associated with Cone Beam CT systems, including the need for national quality and performance standards.”

The session will be moderated by Mr. Carneal and will feature the following speakers:

-William Harrell, Jr., DMD, C. DSM, RadSite Chair, Cone Beam CT Standards Committee, and Assistant Associate Professor at the University of Alabama, Birmingham

-Adam Powell, PhD, RadSite Standards Coordinator and President of the Payer + Provider Syndicate

-Eliot Siegel, MD, RadSite Chief Medical Officer

The webinar is complimentary and pre-registration is strongly encouraged:

-Title: 2020 RadSite ConeBeam CT Standards Overview

-Time: June 17, 2020; 2 p.m. to 3 p.m. ET

-Register: Click here to register..

“The webinar will describe the two-year standards development journey which has incorporated key performance and manufacture requirements with an eye on developing uniform physics metrics for Cone Beam CT in the near future,” Dr. Siegel elaborates. “This dynamic session also will highlight what RadSite has learned about fine-tuning the final requirements during the beta-test accreditation review period.”

“The new Cone Beam CT Accreditation Program will establish the most detailed standards for specialty imaging that are available for this emerging market,” adds Dr. Harrell. “The Standards Committee spent many hours discussing key aspects of what is required to promote quality-based imaging—including scope of practice parameters for various types of dental and medical providers using Cone Beam CT systems for diagnostic imaging.”

“Utilizing the input of numerous clinical and industry experts, we have drafted high-fidelity standards that address key operational issues, such as the role and prerequisite qualifications of the clinical director, interpreting provider, imaging technologist, and other personnel,” said Dr. Powell. “The session will highlight our next steps for launching the new Dental and Medical Cone Beam CT MIPPA Accreditation Programs.”

As part of its spring webinar series, RadSite hosted two other webinars which can still be viewed by registering below:

-2020 RadSite Standards and Accreditation Updates (recorded on April 15, 2020). Click here to register and listen to the webinar.

-Overview of Cone Beam CT Imaging (recorded May 6, 2020) ET. Click here to register and listen to the webinar.

RadSite offers a comprehensive, affordable, quality-based accreditation program that evaluates providers on established industry standards and best practices. Working with health plans and their participating providers helps raise imaging standards through meaningful imaging quality and patient safety protocols. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services and more than 350 payers and radiology benefit managers.

                                                                                 ###

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email: